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Antitubercular activityAbstract A series of compounds 4-oxo-thiazolidine derivatives AJ5a–j were synthesized by conden-
sation reactions. The structure of synthesized compounds was characterized by IR, 1H NMR, 13C
NMR and mass spectroscopy. The present paper deals with newly synthesized thiazolidine com-
pounds AJ5a–AJ5j that were screened for their antimicrobial activity against different strains of
bacteria and fungi using serial broth dilution method (Mueller–Hinton broth dilution method).
In vitro antitubercular activity of compounds AJ5a–j was carried out against Mycobacterium tuber-
culosis H37Rv. Compounds AJ5a, AJ5d, AJ5e, AJ5f and AJ5g were found most active against
selected bacterial strains (MIC = 62.5 lg/mL) and compounds AJ5a–j were found moderately
active against M. tuberculosis.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Tuberculosis is an infection that caregivers in poor countries
face every day. Its treatment does not essentially require a ver-
tical programme and should be a part of regular medical activ-
ities, even when the number of patients is limited. According to
the WHO, eight to ten million new tuberculosis cases are re-ported worldwide, and two million people die due to tubercu-
losis sickness. The growing problem of struggle against
tuberculosis drugs (half a million new cases of multi drug resis-
tance TB annually) has further made tuberculosis management
a difﬁcult task (Balasco et al., 2010; WHO, 2006). The nucleus
of 4-oxo-thiazolidine derivatives has occupied a unique place
in the ﬁeld of medicinal chemistry due to a wide range of bio-
logical activities (Joshi et al., 2001). They have interesting
activity proﬁles mainly cox-1 inhibitors, inhibitors of bacterial
enzyme, non nucleoside inhibitors of HIV Type 1 Reverse
Transcriptase (HIVRT) and antihistaminic agent (Diurno
and Vittnsia, 1999). 4-Oxo-thiazolidines are derivatives of thia-
zolidinone with a carbonyl group at the 4th position formed by
the attack of sulphur nucleophile on imine carbon followed by
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studies on molecular modiﬁcation of the later 1H, 3H-thiazolo
[3,4-a] benzimidazoles (TBZs) revealed that, dismantling of the
imidazole nucleus leading to the design of new 4-oxo-thiazoli-
dine derivatives, maintained the molecular requirements for
enzyme inhibition. A literature search revealed that 4-oxo-thi-
azolidine derivatives may exhibit anti-HIV (Rawal et al., 2005)
enzyme murB (Andres et al., 2000), antimicrobial activity (Sri-
vastava and Srivastava, 2002), antituberclousis (Babaoglu
et al., 2003; Govindarajan et al., 2003) antiproliferative agent
(Ottana` et al., 2005), CNS activity (Basu et al., 2008), cytotoxic
agent (Gududuru et al., 2005), anticonvulsant activity (Archa-
na et al., 2002), antibacterial activity (Bonde and Gaikwad,
2004; Sayyed et al., 2006), analgesic agent (Moustfa et al.,
1989), antiinﬂammetry agent (Vigorita et al., 2001; Goel
et al., 1999), antihypertensive agent (El-subbagh, 1999), and
hypolipidemic agent (Lohary et al., 1999) properties.
2. Synthetic aspects
Syntheses of 4-oxo-thiazolidines have been reported either by
cyclization of acyclic compound or by interconversion among
appropriately substituted 4-oxo-thiazolidine derivatives. Mane
et al. (2001) have synthesized 4-oxo-thiazolidine bearing 2-
mercapto-4-methylimidazoles moiety. Mogilaiah et al. (1999)
have synthesized 2-aryl-3-(2-triﬂuromethyl-1,8-naphthyridine-
3-carbonylamino)-4-thiazolidinones. Synthesis of 4-oxo-
thiazolidine has been reported by the microwave irradiation
(Abdel et al., 1994). Parikh et al. (1980) have synthesized a
variety of 4-oxo-thiazolidine bearing diphenyl sulphone, substi-
tuted aryl arsanilic acid, 2-aryl-1,3,4-thiadiazole,c-picolinylamino,
sulphonamido benzoylamino, phthalazine-1-yl-amino, aryl substi-
tuted hydroxyaryl, b-b-dichloroethylaminophenyl and 8-hydroxy-
quinolinyl moieties. 4-Oxo-thiazolidines have been reported as
potent antimicrobial agents.
In view of above ﬁndings and continuation of our research
programme to ﬁnd effective new antimicrobial and antitubercu-
lar agents for the treatment of infectious diseases, the present
study focused on the synthesis and biological evaluation of some
4-oxo-thiazolidine derivatives AJ5a–j by modiﬁed protocols.
3. Experimental
Melting points are determined on a Gallenkemp melting point
apparatus and are uncorrected. Completion of reaction and
purity of synthesized compounds are checked on aluminium-
coated TLC plates 60 F245 (E. Merck) using benzene:ethyl ace-
tate (8:2 V/V) as mobile phase and visualized under ultraviolet
(UV) light or iodine vapour. All compounds were puriﬁed by
combi ﬂash chromatography using ethylacetate:hexane as elu-
ent. Elemental analysis (% C, H, N) is carried out by a Perkin–
Elmer 2400 CHN analyser. IR spectra of compounds have
been recorded on Thermo-Nicolet FT-IR-200 spectrophotom-
eter in KBr disc (cm1). 1H NMR and 13C NMR spectra are
recorded on Bruker DRX (200 MHz) spectrometer using
CDCl3 as a solvent and TMS as an internal standard. Chemi-
cal shifts are reported in parts per million (dppm). Mass spectra
of synthesized compounds (AJ5a–j) were carried out using the
shimadzu GC–MS (Shimadzu 2010 plus) direct probe method.
Compounds (AJ5a–j) were synthesized by using Random syn-
thesizer Syrris IKA-RCA with safety control.3.1. Preparation of (E)-N0-(4-chlorobenzylidene)-2-(3-(4-
ﬂuorophenyl)-4-oxo-3,4-dihydroquinazolin-2-ylthio)
acetohydrazide (4a)
Amixture of compound (3) (0.01 mol) and 4-chlorobenzaldehyde
(0.01 mol) in ethanol was reﬂuxed. During the reﬂuxing period 2–
3 drops of acetic acid was added and the reaction mixture was re-
ﬂuxed for 8 h. The product was ﬁltered and washing with sodium
bicarbonate solution was carried out to remove excess of acidity.
The intermediate product was crystallized from methanol and
chloroform (1:1, v/v) mixture to yield compound (4a). Similarly,
compound (4b–j) is also prepared using a similar method.
3.2. General procedure for synthesis of N-(2-(4-chlorophenyl)-
4-oxothiazolidin-3-yl)-2-((3-(4-ﬂuorophenyl)-4-oxo-3,4-
dihydroquinazolin-2-yl)thio)acetamide (AJ5a–j)
A mixture of compound 4a–j (0.01 mol) in dioxan and mer-
capto acetic acid (0.01 mol) with a pinch of ZnCl2 was reﬂuxed
for about 10 h. The separated solid was crystallized from eth-
anol to get compounds (AJ5a–j).
3.3. Elemental and characterization data of 3-(4-ﬂuorophenyl)-
2-mercaptoquinazolin-4(3H)-one (1)
This was prepared according to the literature method (Sanja
et al., 2007).
Yield: 75%. M. p.-263 C. IR (KBr): 1193 cm1 (–C–O
stretching), 1310 cm1 (Ar–C–H bending of –CH2), 835 cm
1
(p-substituted benzene ring), 653 cm1 (C–S stretching),
1730 cm1(C‚O stretching of benzene ring), 1490 cm1 (Ar–
C‚C aromatic stretching band), 968 cm1 (–C–F stretching
in benzene ring), 1632 cm1 (C‚N stretching in quinoline).
1H NMR (CDCl3, 200 MHz): d 6.612–7.165 ppm (s, 8H, –
Ar–H), d 2.440 ppm (s, 1H, –SH of thiole). 13C NMR (CDCl3,
200 MHz): d 115.7–162.9 ppm (Ar–C, 8C benzene ring), d
160.6 ppm (Ar–C‚O, 1C of quinoline), d 146.9, 128.3 ppm
(Ar–C–N, 2C of quinoline), d 159.3 ppm (Ar–C–SH, 1C of thi-
ole), d 162.9 ppm (Ar–C–F, 1C of aniline), d 120.9 ppm (Ar–
C–C, 1C of benzene ring). MS: m/z (relative intensity %),
(73%) M+224 amu Anal Calcd (%) for C14H9FN2OS: C.
61.75; H, 3.33 N. 10.29; Found: C. 61.74; H, 3.32; N. 10.29.
3.4. Elemental and characterization data of ethyl 2-(3-(4-
ﬂuorophenyl)-4-oxo-3,4-dihydroquinazolin-2-ylthio)acetate (2)
The equimolar solution of compound 1 (0.1 mol) and ethyl
chloro acetate (0.1 mol) in dry acetone (35 mL) in the presence
of K2CO3 (0.15 mol) was reﬂuxed on a water bath for about
12 h. The reaction mixture was poured on ice to get a solid
product, and was washed with methanol. Compound (2) is
crystallized in ethanol to get compound (2).
Yield: 73%. M. p.- 186 C. IR (KBr): 1194 cm1 (–C–O
stretching), 1312 cm1 (Ar–C–H bending) 833 cm1 (p-substi-
tuted benzene ring), 656 cm1 (C–S stretching),
1732 cm1(C‚O stretching of benzene ring), 1492 cm1 (Ar–
C‚C aromatic stretching band), 966 cm1 (–C–F stretching
in benzene ring), 1634 cm1 (C‚N stretching of quinoline),
2930 cm1 (–CH stretching –CH3 & –CH2).
1H NMR (CDCl3,
200 MHz): d 6.614–7.167 ppm (s, 8H, –Ar–H), d 2.440 ppm (s,
1H, –SH of thiole), d 4.123 ppm (s, 3H, –CH3 of ester) d
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13C NMR (CDCl3,
200 MHz): d 115.5–162.7 ppm (Ar–C, 8C benzene ring), d
160.5 ppm (Ar–C‚O, 1C of quinoline), d 146.7, 128.2 ppm
(Ar–C–N, 2C of quinoline), d 159.4 ppm (Ar–C–S, 2C of es-
ter), d 30.7 ppm (–C–C‚O, 1C of ester), d 169.2 ppm (C–
C‚O, 1C of thiole), d 162.5 ppm (Ar–C–F, 1C), d 120.3 and
146.8 ppm (Ar–C‚C, 2C of benzene ring). MS: m/z (relative
intensity %), (72%) M+274 amu Anal Calcd (%) for
C18H15FN2O3S: C, 60.32; H, 4.22; N, 7.82%); Found: C,
60.31; H, 4.21; N, 7.82%.
3.5. Elemental and characterization data of 2-(3-(4-
ﬂuorophenyl)-4-oxo-3,4-dihydroquinazolin-2-
ylthio)acetohydrazide (3)
An equimolar ratio of compound (2) (0.1 mol) and hydrazine
hydrate (0.1 mol) was reﬂuxed in ethanol (40 mL) for about
2 h, after cooling of the mixture product was separated, ﬁl-
tered, washed with water and crystallized in ethanol to get
compound (3).
Yield: 77%. M. p.- 127 C. IR (KBr): 1193 cm1 (–C–O
stretching), 1311 cm1 (Ar–C–H bending) 835 cm1 (p-substi-
tuted benzene ring), 658 cm1 (C–S stretching), 1735 cm1(C‚O
stretching of benzene ring), 1493 cm1 (Ar–C‚C aromatic
stretching band), 966 cm1 (–C–F stretching in benzene ring),
1636 cm1 (C‚N stretching in quinoline), 2934 cm1 (–CH
stretching –CH3 & –CH2), 3465 cm
1 (–NH stretching of primary
amide), 3365 cm1 (–NH stretching of secondary amide). 1H
NMR (CDCl3, 200 MHz): d 6.613–7.166 ppm (s, 8H, –Ar–H), d
2.444 ppm (s, 2H, –S–CH2 of thiole), d 8.213 ppm (–NH, 1H, sec-
ondary amide), d 2.123 ppm (–NH2, 2H, primary amine).
13C
NMR (CDCl3, 200 MHz): d 115.3–162.4 ppm (Ar–C, 8C benzene
ring), d 160.3 ppm (Ar–C‚O, 1C of quinoline), d 146.5,
128.3 ppm (Ar–C–N, 2C of quinoline), d 159.4 ppm (Ar–C–S,
1C, of quinoline), d 30.5 ppm (–C–C‚O, 1C of ester),d
169.3 ppm (C–C‚O, 1C of thiole), d 162.3 ppm (Ar–C–F, 1C).
MS: m/z (relative intensity %), (73%) M+314 amu Anal Calcd
(%) for C16H13FN4O2S: C, 55.80; H, 3.81; N, 16.27%); Found:
C, 55.79; H, 3.81; N, 16.27%.
3.6. Elemental and characterization data of compound (4a)
Yield: 66%.M. p.- 252 C. IR (KBr): 1196 cm1 (–C–O stretch-
ing of benzene), 1315 cm1 (Ar–C–H bending), 837 cm1 (p-
substituted benzene ring), 656 cm1 (Ar-S stretching in benzene
ring), 1738 cm1(C‚O stretching of benzene ring), 1494 cm1
(Ar-C‚C aromatic stretching band), 968 cm1 (–C–F stretch-
ing in benzene ring), 1634 cm1 (C‚N stretching in quinoline),
2936 cm1 (–CH stretching –CH3 & –CH2), 3463 cm
1 (–NH
stretching of primary amide), 3366 cm1 (–NH stretching of
secondary amide), 825 cm1 (Ar–Cl stretching band of Schiff
base). 1H NMR (CDCl3, 200 MHz): d 7.523–8.635 ppm (s,
12H, –Ar–H), d 2.446 ppm (s, 2H, –S–CH2 of thiole), d
8.314 ppm (O‚C–NH, 1H of hydrazide) d 3.852 ppm (Ar–
NH, 1H of hydrazide). 13C NMR (CDCl3, 200 MHz): d
115.7–171.0 ppm (Ar–C, 12C benzene ring), d 160.3 ppm
(Ar–C‚O, 1C of quinoline), d 146.5, 128.5 ppm (Ar–C–N,
2C of quinoline), d 30.8 ppm (O‚C–C, 1C of ester), d
159.5 ppm (Ar–C–S, 1C, of quinoline), d 171.0 ppm (NH–
C‚O, 1C of hydrazide), d 162.3 ppm (Ar–C–F, 1C) d
136.5 ppm (Ar–Cl, 1C, of Schiff base), 120.8 ppm, d 131.5(Ar–C‚C 2C), d 144.5 ppm (NH–N‚C, 1C, of hydrazide).
MS: m/z (relative intensity.%), (73%) M+342 amu Anal Calcd
(%) for C23H16ClFN4O2S: C, 59.17; H, 3.44; N, 12.60%);
Found: C, 59.16; H, 3.44; N, 12.60%.
3.7. Elemental and characterization data of compound (4b)
Yield: 67%.M. p.- 217 C. IR (KBr): 1195 cm1 (–C–O stretch-
ing of benzene), 1317 cm1 (Ar–C–H bending), 836 cm1 (p-
substituted benzene ring), 652 cm1 (C–S stretching),
1734 cm1(C‚O stretching of benzene ring), 1492 cm1 (Ar–
C‚C aromatic stretching band), 965 cm1 (Ar–F stretching),
1633 cm1 (C‚N stretching in quinoline), 2935 cm1 (–CH
stretching –CH3 & –CH2), 3464 cm
1 (–NH stretching of pri-
mary amide), 3368 cm1 (–NH stretching of secondary amide),
1513, 1356 cm1 (Ar–NO2 stretching band of Schiff base).
1H
NMR (CDCl3, 200 MHz): d 7.632–8.635 ppm (s, 8H, –Ar–H),
d 3.986 ppm (s, 2H, –S–CH2 of thiole), d 8.312 ppm (O‚C–
NH, 1H of hydrazide) d 3.854 ppm (Ar–NH, 1H of hydrazide)
7.590–8.098 ppm (s, 4H, –Ar–H of aldehyde). 13C NMR
(CDCl3, 200 MHz): d 115.7–132.4 ppm (Ar–C, 12C benzene
ring), d 160.6 ppm (Ar–C‚O, 1C of quinoline), d 146.5,
128.5 ppm (Ar–C–N, 2C of quinoline), d 30.8 ppm (O‚C–C,
1C of ester), d 159.5 ppm (Ar–C–S, 1C, of quinoline), d
171.0 ppm (NH–C‚O, 1C of hydrazide), d 162.9 ppm (Ar–
C–F, 1C) d 136.5 ppm (Ar–C, 1C, of Schiff base), 120.8 ppm,
d 131.5 (Ar–C‚C 2C), d 144.5 ppm (NH–N‚C, 1C, of hydra-
zide). MS: m/z (relative intensity %), (75%) M+356 amu
Chemical formula: C23H16FN5O4S: Anal Calcd (%): C, 57.86;
H, 3.38; N, 14.67; Found: C, 57.85; H, 3.37; N, 14.66%.
3.8. Elemental and characterization data of compound (4c)
Yield: 59%.M. p.- 223 C. IR (KBr): 1196 cm1 (–C–O stretch-
ing), 1312 cm1 (Ar–C–H bending), 836 cm1 (p-substituted
benzene ring), 652 cm1 (C–S stretching), 1733 cm1(C‚O
stretching of benzene ring), 1499 cm1 (Ar–C‚C Aromatic
stretching band), 972 cm1 (Ar–F stretching), 1632 cm1
(C‚N stretching in quinoline), 2934 cm1 (–CH stretching –
CH3 & –CH2), 3464 cm
1 (–NH stretching of primary amide),
3368 cm1 (–NH stretching of secondary amide), 1517,
1347 cm1 (Ar–C–NO2 stretching band of Schiff base).
1H
NMR (CDCl3, 200 MHz): d 7.632–8.635 ppm (s, 8H, –Ar–
H), d 3.986 ppm (s, 2H, –S–CH2 of thiole), d 8.312 ppm
(O‚C–NH, 1H of hydrazide) d 3.854 ppm (Ar–NH, 1H of
hydrazide) 7.590–8.098 ppm (s, 4H, –Ar–H of aldehyde). 13C
NMR (CDCl3, 200 MHz): d 115.7–132.4 ppm (Ar–C, 12C ben-
zene ring), d 160.6 ppm (Ar–C‚O, 1C of quinoline), d 146.5,
128.5 ppm (Ar–C–N, 2C of quinoline), d 30.8 ppm (O‚C–C,
1C of ester), d 159.5 ppm (Ar–C–S, 1C, of quinoline), d
171.0 ppm (NH–C‚O, 1C of hydrazide), d 162.9 ppm (Ar–
C–F, 1C) d 136.5 ppm (Ar–C, 1C, of Schiff base), 120.8 ppm,
d 131.5 (Ar–C‚C 2C), d 144.5 ppm (NH–N‚C, 1C, of hydra-
zide). MS: m/z (relative intensity %), (78%) M+314 amu
Chemical formula: C23H16FN5O4S: Anal Calcd (%): C,
57.86; H, 3.38; N, 14.67; Found: C, 57.85; H, 3.37; N, 14.66%.
3.9. Elemental and characterization data of compound (4d)
Yield: 69%.M. p.- 248 C. IR (KBr): 1195 cm1 (–C–O stretch-
ing), 1317 cm1 (Ar–C–H bending), 840 cm1 (p-substituted
S526 D.R. Godhani et al.benzene ring), 658 cm1 (C–S stretching), 1740 cm1(C‚O
stretching of benzene ring), 1495 cm1 (Ar–C‚C Aromatic
stretching band), 966 cm1 (Ar–F stretching), 1636 cm1
(C‚N stretching in quinoline), 2934 cm1 (–CH stretching –
CH3 & –CH2), 3461 cm
1 (–NH stretching of primary amide),
3361 cm1 (–NH stretching of secondary amide), 824 cm1
(Ar–Cl stretching band of Schiff base). 1H NMR (CDCl3,
200 MHz): d 7.527–8.638 ppm (s, 12H, –Ar–H), d 2.442 ppm
(s, 2H, –S–CH2 of thiole), d 8.316 ppm (O‚C–NH, 1H of
hydrazide) d 3.858 ppm (Ar–NH, 1H of hydrazide). 13C
NMR (CDCl3, 200 MHz): d 115.2–170.3 ppm (Ar–C, 12C ben-
zene ring), d 160.5 ppm (Ar–C‚O, 1C of quinoline), d 144.5,
128.1 ppm (Ar–C–N, 2C of quinoline), d 30.9 ppm (O‚C–C,
1C of ester), d 159.4 ppm (Ar–C–S, 1C, of quinoline), d
170.2 ppm (NH–C‚O, 1C of hydrazide), d 162.5 ppm (Ar–
C–F, 1C) d 147.2 ppm (Ar–C–Cl, 1C, of Schiff base),
120.8 ppm, d 131.5 (Ar–C‚C 2C), d 143.5 ppm (NH–N‚C,
1C, of hydrazide). MS: m/z (relative intensity %), (71%)
M+358 amu Anal Calcd (%) for C23H16ClFN4O2S: C, 59.17;
H, 3.44; N, 12.60%); Found: C, 59.16; H, 3.43; N, 12.59%.
3.10. Elemental and characterization data of compound (4e)
Yield: 67%.M. p.- 236 C. IR (KBr): 1185 cm1 (–C–O stretch-
ing), 1322 cm1 (Ar–C–H bending), 842 cm1 (p-substituted
benzene ring), 662 cm1 (C–S stretching), 1741 cm1(C‚O
stretching of benzene ring), 1491 cm1 (Ar–C‚C Aromatic
stretching band), 970 cm1 (Ar–F stretching), 1642 cm1
(C‚N stretching in quinoline), 2928 cm1 (–CH stretching –
CH3 & –CH2), 3455 cm
1 (–NH stretching of primary amide),
3358 cm1 (–NH stretching of secondary amide), 832 cm1
(Ar–Cl stretching band of Schiff base). 1H NMR (CDCl3,
200 MHz): d 7.522–8.646 ppm (s, 12H, –Ar–H), d 2.438 ppm
(s, 2H, –S–CH2 of thiole), d 8.322 ppm (O‚C–NH, 1H of
hydrazide) d 3.863 ppm (Ar–NH, 1H of hydrazide). 13C
NMR (CDCl3, 200 MHz): d 115.4–170.1 ppm (Ar–C, 12C ben-
zene ring), d 160.4 ppm (Ar–C‚O, 1C of quinoline), d 144.3,
128.5 ppm (Ar–C–N, 2C of quinoline), d 30.8 ppm (O‚C–C,
1C of ester), d 159.3 ppm (Ar–C–S, 1C, of quinoline), d
170.3 ppm (NH–C‚O, 1C of hydrazide), d 162.7 ppm (Ar–
C–F, 1C) d 147.4 ppm (Ar–C–Cl, 1C, of Schiff base),
120.7 ppm, d 131.6 (Ar–C‚C 2C), d 143.7 ppm (NH–N‚C,
1C, of hydrazide). MS: m/z (relative intensity %), (78%)
M+354 amu Anal Calcd (%) for C23H16ClFN4O2S: C, 59.17;
H, 3.44; N, 12.60%; Found: C, 59.16; H, 3.44; N, 12.59%.
3.11. Elemental and characterization data of compound (4f)
Yield: 65%.M. p.- 235 C. IR (KBr): 1195 cm1 (–C–O stretch-
ing), 1319 cm1 (Ar–C–H bending), 838 cm1 (p-substituted
benzene ring), 654 cm1 (C–S stretching), 1734 cm1 (C‚O
stretching of benzene ring), 1497 cm1 (Ar–C‚C Aromatic
stretching band), 974 cm1 (Ar–F stretching), 1633 cm1
(C‚N stretching in quinoline), 2932 cm1 (–CH stretching –
CH3 & –CH2), 3462 cm
1 (–NH stretching of primary amide),
3364 cm1 (–NH stretching of secondary amide), 1515,
1349 cm1 (Ar–C–NO2 stretching band of Schiff base).
1H
NMR (CDCl3, 200 MHz): d 7.638–8.638 ppm (s, 8H, –Ar–
H), d 3.985 ppm (s, 2H, –SCH2 of thiole), d 8.314 ppm
(O‚C–NH, 1H of hydrazide) d 3.856 ppm (Ar–NH, 1H of
hydrazide) 7.592–8.088 ppm (s, 4H, –Ar–H of aldehyde). 13CNMR (CDCl3, 200 MHz): d 115.7–132.3 ppm (Ar–C, 12C ben-
zene ring), d 160.2 ppm (Ar–C‚O, 1C of quinoline), d 146.3,
128.3 ppm (Ar–C–N, 2C of quinoline), d 30.4 ppm (O‚C–C,
1C of ester), d 159.4 ppm (Ar–C–S, 1C, of quinoline), d
171.1 ppm (NH–C‚O, 1C of hydrazide), d 162.8 ppm (Ar–
C–F, 1C) d 136.5 ppm (Ar–C, 1C, of Schiff base), 120.6 ppm,
d 131.4 (Ar–C‚C 2C), d 144.4 ppm (NH–N‚C, 1C, of hydra-
zide). MS: m/z (relative intensity %), (73%) M+343 amu
Chemical formula: C23H16FN5O4S: Anal Calcd (%): C,
57.86; H, 3.38; N, 14.67; Found: C, 57.86; H, 3.37; N, 14.67%.
3.12. Elemental and characterization data of compound (4g)
Yield: 52%. M. p.- 223 C. IR (KBr): 1194 cm1 (–C–O
stretching), 1319 cm1 (Ar–C–H bending), 838 cm1 (p-substi-
tuted benzene ring), 654 cm1 (C–S stretching), 1734 cm1
(C‚O stretching of benzene ring and aldehyde), 1497 cm1
(Ar–C‚C Aromatic stretching band), 974 cm1 (Ar–F
stretching), 1633 cm1 (C‚N stretching in quinoline),
2937 cm1 (–CH stretching –CH3 & –CH2), 3466 cm
1 (–NH
stretching of primary amide), 3364 cm1 (–NH stretching of
secondary amide), 2830, 2864 cm1 (Ar–OCH3 stretching band
of Schiff base). 1H NMR (CDCl3, 200 MHz): d 7.642–
8.636 ppm (s, 8H, –Ar–H), d 3.984 ppm (s, 2H, –S–CH2 of thi-
ole), d 8.316 ppm (O‚C–NH, 1H of hydrazide) d 3.858 ppm
(Ar–NH, 1H of hydrazide) d 7.592–8.088 ppm (s, 4H, –Ar–H
of aldehyde). d 2.289 ppm (s, 3H, –Ar–OCH3 of aldehyde).
(13C NMR CDCl3, 200 MHz): d 114.3–132.7 ppm (Ar–C,
12C benzene ring), d 160.2 ppm (Ar–C‚O, 1C of quinoline),
d 146.3, 128.3 ppm (Ar–C–N, 2C of quinoline), d 30.4 ppm
(O‚C–C, 1C of ester), d 159.4 ppm (Ar–C–S, 1C, of quino-
line), d 171.1 ppm (NH–C‚O, 1C of hydrazide), d
162.8 ppm (Ar–C–F, 1C) d 136.5 ppm (Ar–C, 1C, of Schiff
base), 120.6 ppm, d 131.4 (Ar–C‚C, 2C), d 144.4 ppm (NH–
N‚C, 1C, of hydrazide), d 55.8 ppm (Ar–OCH3, 1C, of alde-
hyde). MS: m/z (relative intensity %), (68%) M+344 amu
Chemical formula: C24H19FN4O3S: Anal Calcd (%): C,
62.33; H, 3.37; N, 12.11; Found: C, 62.32; H, 3.37; N, 12.10%.
3.13. Elemental and characterization data of compound (4h)
Yield: 56%. M. p.- 231 C. IR (KBr): 1198 cm1 (–C–O
stretching), 1321 cm1 (Ar–C–H bending), 841 cm1 (p-substi-
tuted benzene ring), 656 cm1 (C–S stretching), 1737 cm1
(C‚O stretching of benzene ring), 1495 cm1 (Ar–C‚C Aro-
matic stretching band), 974 cm1 (Ar–F stretching), 1637 cm1
(C‚N stretching in quinoline), 2936 cm1 (–CH stretching –
CH3 & –CH2), 3469 cm
1 (–NH stretching of primary amide),
3359 cm1 (–NH stretching of secondary amide), 1156,
1752 cm1 (Ar–OH stretching band of Schiff base). 1H
NMR (CDCl3, 200 MHz): d 7.652–8.642 ppm (s, 8H, –Ar–
H), d 3.975 ppm (s, 2H, –S–CH2 of thiole), d 8.314 ppm
(O‚C–NH, 1H of hydrazide) d 3.862 ppm (Ar–NH, 1H of
hydrazide) d 7.588–8.063 ppm (s, 4H, –Ar–H of aldehyde). d
2.386 ppm (s, 1H, –Ar–OH of aldehyde substitution group).
13C NMR (CDCl3, 200 MHz): d 115.3–131.3 ppm (Ar–C,
12C benzene ring), d 160.3 ppm (Ar–C‚O, 1C of quinoline),
d 145.3, 128.4 ppm (Ar–C–N, 2C of quinoline), d 30.8 ppm
(O‚C–C, 1C of ester), d 159.5 ppm (Ar–C–S, 1C, of quino-
line), d 171.3 ppm (NH–C‚O, 1C of hydrazide), d
162.7 ppm (Ar–C–F, 1C) d 136.5 ppm (Ar–C, 1C, of Schiff
Synthesis, characterization and biological evaluation of 4-oxo-thiazolidine compounds S527base), 120.6 ppm, d 131.5 (Ar–C‚C, 2C), d 144.3 ppm (NH–
N‚C, 1C, of hydrazide). MS: m/z (relative intensity %),
(62%) M+354 amu Chemical Formula: C23H17FN4O3S: Anal
Calcd (%): C, 62.33; H, 3.82; N, 12.49; Found: C, 62.33; H,
3.81; N, 12.48%.3.14. Elemental and characterization data of compound (4i)
Yield: 53%. M. p.- 236 C. IR (KBr): 1196 cm1 (–C–O
stretching), 1325 cm1 (Ar–C–H bending), 843 cm1 (p-substi-
tuted benzene ring), 658 cm1 (C–S stretching),
1739 cm1(C‚O stretching of benzene ring), 1497 cm1 (Ar–
C‚C Aromatic stretching band), 977 cm1 (Ar–F stretching),
1639 cm1 (C‚N stretching in quinoline), 2938 cm1 (–CH
stretching –CH3 & –CH2), 3465 cm
1 (–NH stretching of pri-
mary amide), 3334 cm1 (–NH stretching of secondary amide),
1153, 1758 cm1 (Ar–OH stretching band of Schiff base). 1H
NMR (CDCl3, 200 MHz): d 7.656–8.644 ppm (s, 8H, –Ar–
H), d 3.974 ppm (s, 2H, –S–CH2 of thiole), d 8.315 ppm
(O‚C–NH, 1H of hydrazide) d 3.863 ppm (Ar–NH, 1H of
hydrazide) d 7.588–8.065 ppm (s, 4H, –Ar–H of aldehyde). d
2.389 ppm (s, 1H, –Ar–OH of aldehyde substitution group).
13C NMR (CDCl3, 200 MHz): d 115.5–131.6 ppm (Ar–C,
12C benzene ring), d 160.5 ppm (Ar–C‚O, 1C of quinoline),
d 145.5, 128.3 ppm (Ar–C–N, 2C of quinoline), d 30.9 ppm
(O‚C–C, 1C of ester), d 159.3 ppm (Ar–C–S, 1C, of quino-
line), d 171.5 ppm (NH–C‚O, 1C of hydrazide), d
162.5 ppm (Ar–C–F, 1C) d 136.4 ppm (Ar–C, 1C, of Schiff
base), 120.5 ppm, d 131.8 (Ar–C‚C, 2C), d 144.2 ppm (NH–
N‚C, 1C, of hydrazide). MS: m/z (relative intensity %),
(61%) M+342 amu Chemical formula: C23H17FN4O3S: Anal
Calcd (%): C, 62.33; H, 3.82; N, 12.49; Found: C, 62.32; H,
3.82; N, 12.48%.3.15. Elemental and characterization data of compound (4j)
Yield: 76%. M. p.- 228 C. IR (KBr): 1189 cm1 (–C–O
stretching), 1332 cm1 (Ar–C–H bending), 846 cm1 (p-substi-
tuted benzene ring), 662 cm1 (C–S stretching),
1741 cm1(C‚O stretching of benzene ring), 1492 cm1 (Ar–
C‚C Aromatic stretching band), 981 cm1 (Ar–F stretching),
1642 cm1 (C‚N stretching in quinoline), 2940 cm1 (–CH
stretching –CH3 & –CH2), 3462 cm
1 (–NH stretching of pri-
mary amide), 3331 cm1 (–NH stretching of secondary amide).
1H NMR (CDCl3, 200 MHz): d 7.642–8.638 ppm (s, 8H, –Ar–
H), d 3.971 ppm (s, 2H, –S–CH2 of thiole), d 8.312 ppm
(O‚C–NH, 1H of hydrazide) d 3.858 ppm (Ar–NH, 1H of
hydrazide) d 7.579–8.062 ppm (s, 4H, –Ar–H of aldehyde).
13C NMR (CDCl3, 200 MHz): d 114.8–135.4 ppm (Ar–C,
12C benzene ring), d 160.8 ppm (Ar–C‚O, 1C of quinoline),
d 144.3, 127.8 ppm (Ar–C–N, 2C of quinoline), d 30.2 ppm
(O‚C–C, 1C of ester), d 159.6 ppm (Ar–C–S, 1C, of quino-
line), d 171.6 ppm (NH–C‚O, 1C of hydrazide), d
161.2 ppm (Ar–C–F, 1C) d 134.4 ppm (Ar–C, 1C, of Schiff
base), 121.4 ppm, d 132.7 (Ar–C‚C, 2C), d 144.3 ppm (NH–
N‚C, 1C, of hydrazide). MS: m/z (relative intensity %),
(73%) M+356 amu Chemical formula: C23H16F2N4O2S: Anal
Calcd (%): C, 61.33; H, 3.58; N, 12.44; Found: C, 61.32; H,
3.57; N, 12.43%.4. Statistical analysis
Standard deviation value is expressed in terms of ± SD. On
the basis of the calculated value by using a one-way ANOVA
method followed by an independent two sample t test, it has
been observed that differences below 0.001 level are considered
as statistically signiﬁcant. Compounds were screened for their
antibacterial, antifungal and antitubercular activities in six sets
(n) against bacteria and fungi used in the protocol herein.5. Results and discussion
5.1. Chemistry
Newly synthesized 4-oxo-thiazolidine derivatives are depicted
in Scheme 1. According to the modiﬁed protocol compounds
were prepared.(Sanja et al., 2007; Sanghani et al., 2008; Myan-
gar et al., 2012; Myangar and Raval, 2012; Kumar et al., 2007;
Mashelkar and Rane, 2005; Sharma et al., 2012; Shiradkar
et al., 2007; Narute et al., 2008).
The synthesis of title compounds was accomplished as out-
lined in Scheme 1. In the ﬁrst step, quinazoline-2-thione deriv-
atives were prepared by condensation of p-ﬂouroaniline and
anthranilic acid in the presence of carbon disulphide and
potassium hydroxide as basic media to give compound 1. In
compound 1, thiol group contains free hydrogen and so con-
densation reaction takes place at this thiol group. Compound
1 was reacted with ethylchlorocetate in the presence of base
like potassium carbonate and acetone as solvent to give com-
pound 2. The reaction was carried out with good yields and
thiol was condensed with chloro ester and the removal of
hydrochloric acid as by product. Compound 2 was reacted
with hydrazine hydrate in the presence of ethanol as a solvent
to give hydrazide (compound 3). The hydrazide (compound 3)
reacts with a different substituent pair of aldehyde in the pres-
ence of glacial acetic acid as catalyst and ethanol as solvent to
give compounds 4a–j. Further, compound 4a–j reﬂuxed with
thioglycolic acid in 1,4-dioxan to yield the ﬁnal product of
compounds AJ5a–j.
The IR spectrum of the compounds AJ5a (molecular for-
mula C25H18ClFN4O3S2 m.w. 541) clearly shows as C‚O cyc-
lic stretching vibration band found at 1730 cm1, medium
intensity absorption peak at 1654 cm1 is due to a stretching
vibration band, while ring skeletal C‚C shows medium inten-
sity absorption stretching vibration bands at 1507 and
1543 cm1 respectively. C–N stretching vibration band at
1272 cm1 and high frequency region of IR spectra of this
compound containing vibration of N–H stretching vibration
band at 3206 cm1 were observed. 4-Oxo-thiazolidine ring
responding to amine and C–S stretching band was found at
1094 cm1. The presence of 1,2,3-trisubstituted benzene ring
was conﬁrmed due to absorption bands at 716 and 809 cm1
respectively. The presence of substituted benzene ring was also
conﬁrmed with weak intensity absorption peaks corresponding
to a low frequency region at 689 cm1 of synthesized com-
pound AJ5a.
1H NMR spectra of compound AJ5a suggest that pro-
tons are attached to chemically equivalent environment in
compound AJ5a. A singlet appeared around d= 8.169 ppm
S528 D.R. Godhani et al.suggesting the presence of amide group in the basic skeleton. A
singlet is observed around d= 3.835 ppm indicating the pres-
ence of –SH group in thiazolidine ring. The deviation of NMR
signals is attributed to the presence of oxygen atom to the
adjacent carbon atom. Total 13 protons of aromatic rings ap-
peared as multiplets around d= 6.611–7.203 ppm, which sug-
gest chemically equal environment of protons. The 1H NMR
results suggest that a thiazolidine ring structure with amide
group is possibly present in the basic skeleton.
13C NMR of compound AJ5a is in good agreement with re-
sults of 1H NMR. The presence of –S–CH2 group is due to a
signal at d= 31.5 ppm. The presence of thiazolidine –SCH is
conﬁrmed with a signal around d= 36.2 ppm. The presence
of aromatic carbons is conﬁrmed with signals between
d= 121 and 137 ppm with respect to TMS, which suggest
chemically equal environment. The presence of –C‚O groups
is due to signals appearing between d= 160.5 and 170.2 ppm.
Overall, a thiazolidine ring with aromatic basic skeleton and
carbonyl groups are attributed to the results of proton and car-
bon NMR spectrum.
GC–MS data suggest that m/z for compound AJ5a was 423
with the highest relative abundance (73%).
Based on analytical and spectral evidence the predicated
structure of compound AJ5a is depicted in the Fig. 1A.
Other compounds of the series were also prepared using a
similar method and their elemental data are given in Table 1.
(AJ5b–j)
5.2. Characterization and elemental data of 2-(3-(4-
ﬂuorophenyl)-4-oxo-3,4-dihyroquinazolin-2-ylthio)-N-(2-(2-
nitrophenyl)-4-oxothiazolidine-3-yl)acetamide (AJ5b)
Yield: 63%. M.p.- 243 C. IR (KBr): 1194 cm1 (–C–O stretch-
ing), 1340 cm1 (Ar–C–H bending), 876 cm1 (p-substituted
benzene ring), 689 cm1 (C–S stretching), 1738 cm1(C‚O
stretching of benzene ring), 1440 cm1 (Ar–C‚C Aromatic
stretching band), 1018 cm1 (Ar–F stretching), 1652 cm1
(C‚N stretching in quinoline), 2934 cm1 (–CH stretching –
CH3 & –CH2), 3204 cm
1 (–NH stretching of primary amide),
3145 cm1 (–NH stretching of secondary amide), 1508,
1353 cm1 (Ar–C–NO2 stretching band of Schiff base).
1H
NMR (CDCl3, 200 MHz): d 6.613–7.173 ppm (s, 12H, –Ar–
H), d 2.246 (s, 1H, attached thiazolidine ring), 3.835 ppm (s,
1H –1H of thiazolidine ring), 2.442 ppm (s, 2H –S–CH2), d
8.314 ppm (O‚C–NH, 1H of hydrazide) d 3.852 ppm (Ar–Table 1 Elememental data of the prepared compounds (AJ5a–j).
Compound code Ar Molecular formula % Yield
AJ5a 4-Cl–C6H4 C25H18ClFN4O3S2 67
AJ5b 2-NO2–C6H4 C25H18FN5O5S2 63
AJ5c 3-NO2–C6H4 C25H18FN5O5S2 53
AJ5d 2-Cl–C6H4 C25H18ClFN4O3S2 61
AJ5e 3-Cl–C6H4 C25H18ClFN4O3S2 60
AJ5f 4-NO2–C6H4 C25H18FN5O5S2 62
AJ5g 4-OCH3–C6H4 C26H21FN4O4S2 53
AJ5h 2-OH–C6H4 C25H19FN4O4S2 58
AJ5i 3-OH–C6H4 C25H19FN4O4S2 63
AJ5j 4-F–C6H4 C25H18F2N4O3S2 62NH, 1H of hydrazide). 13C NMR (CDCl3, 200 MHz): d
115.8–170.1 ppm (Ar–C, 12C benzene ring), d 160.4 ppm
(Ar–C‚O, 1C of quinoline), d 146.3, 128.6 ppm (Ar–C–N,
2C of quinoline), d 30.6 ppm (O‚C–C, 1C of ester), d
160.4 ppm (Ar–C–S, 1C, of quinoline), d 170.1 ppm (NH–
C‚O, 1C of hydrazide), d 162.9 ppm (Ar–C–F, 1C) d
133.4 ppm (Ar–C–NO2, 1C, of Schiff base), 120.8 ppm, d
132.7 (Ar–C‚C 2C), d 146.3 ppm (NH–N‚C, 1C, of hydra-
zide), d 168.3 ppm (–C‚O, 1C of thiazolidine ring), d
35.6 ppm (–C–SH, 1C of thiazolidine ring) MS: m/z (relative
intensity.%), (73%) M+353 amu Anal Calcd (%) for
C25H18FN4O2S: C, 55.50; H, 3.35; N, 10.36%); Found: C,
55.49; H, 3.34; N, 10.36%. (See Figs 1 and 2).
5.3. Characterization and elemental data of 2-(3-(4-
ﬂuorophenyl)-4-oxo-3,4-dihyroquinazolin-2-ylthio)-N-(2-(3-
nitrophenyl)-4-oxothiazolidine-3-yl)acetamide (AJ5c)
Yield: 53%. M.p.- 254 C. IR (KBr): 1157 cm1 (–C–O
stretching), 1340 cm1 (Ar–C–H bending), 876 cm1 (p-
substituted benzene ring), 689 cm1 (C–S stretching),
1731 cm1(C‚O stretching of benzene ring), 1440 cm1
(Ar–C‚C Aromatic stretching band), 1018 cm1 (Ar–F
stretching), 1650 cm1 (C‚N stretching in quinoline),
2932 cm1 (–CH stretching –CH3 & –CH2), 3209 cm
1
(–NH stretching of primary amide), 3144 cm1 (–NH
stretching of secondary amide), 1508, 1356 cm1 (Ar–C–
NO2 stretching band of Schiff base).
1H NMR (CDCl3,
200 MHz): d 6.614–7.175 ppm (s, 12H, –Ar–H), d 2.245 (s,
1H, attached thiazolidine ring), 3.837 ppm (s, 1H –1H of thi-
azolidine ring), 2.444 ppm (s, 2H –S–CH2), d 8.169 ppm
(O‚C–NH, 1H of hydrazide) d 3.854 ppm (Ar–NH, 1H of
hydrazide). 13C NMR (CDCl3, 200 MHz): d 115.9–
170.2 ppm (Ar–C, 12C benzene ring), d 160.3 ppm (Ar–
C‚O, 1C of quinoline), d 145.3, 128.7 ppm (Ar–C–N, 2C
of quinoline), d 30.5 ppm (O‚C–C, 1C of ester), d
160.5 ppm (Ar–C–S, 1C, of quinoline), d 170.0 ppm (NH–
C‚O, 1C of hydrazide), d 162.8 ppm (Ar–C–F, 1C) d
133.3 ppm (Ar–C–NO2, 1C, of Schiff base), 120.7 ppm, d
132.6 (Ar–C‚C 2C), d 146.2 ppm (NH–N‚C, 1C, of
hydrazide), d 168.2 ppm (–C‚O, 1C of thiazolidine ring),
d 35.7 ppm (–C–SH, 1C of thiazolidine ring) MS: m/z (rela-
tive intensity.%) (67%) M+353 amu Anal Calcd (%) for
C25H18FN4O2S: C, 55.50; H, 3.35; N, 10.36%); Found: C,
55.49; H, 3.35; N, 10.36% (See Table 2).M.P.
C
Elemental analysis %
C H N
Req Obs Req Obs Req Obs
253 57.24 57.23 3.46 3.45 10.68 10.68
243 55.50 54.49 3.35 3.34 10.36 10.36
254 55.50 55.49 3.35 3.35 10.36 10.35
254 55.50 55.49 3.36 3.36 10.36 10.35
242 55.50 55.50 3.36 3.35 10.37 10.36
246 54.44 54.43 3.29 3.28 12.70 12.70
278 58.20 58.18 3.94 3.93 10.40 10.40
234 57.46 57.45 3.66 3.66 10.72 10.71
267 57.24 57.23 3.46 3.45 10.68 10.68
246 57.24 57.23 3.46 3.45 10.68 10.67
Figure 1 Reaction scheme of the 2-(3-(4-ﬂuorophenyl)-4-oxo-3,4-dihyroquinazolin-2-ylthio)-N-(2-(4-chlorophenyl)-4-oxothiazolidin-3-
yl)acetamide.
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chlorophenyl)-4-oxothiazolidin-3-yl)-2-((3-(4-ﬂuorophenyl)-4-
oxo-3,4-dihydroquinazolin-2-yl)thio)acetamide (AJ5d)
Yield: 61%. M.p.- 254 C. IR (KBr): 1157 cm1 (–C–O
stretching), 1341 cm1 (Ar–C–H bending), 876 cm1 (p-
substituted benzene ring), 689 cm1 (C–S stretching),
1731 cm1(C‚O stretching of benzene ring), 1440 cm1
(Ar–C‚C Aromatic stretching band), 1019 cm1 (Ar–F
stretching), 1653 cm1 (C‚N stretching in quinoline),
2933 cm1 (–CH stretching –CH3 & –CH2), 3202 cm
1
(–NH stretching of primary amide), 3145 cm1 (–NH stretch-
ing of secondary amide), 1508, 1357 cm1 (Ar–C–NO2
stretching band of Schiff base). 1H NMR (CDCl3,
200 MHz): d 6.612–7.173 ppm (s, 12H, –Ar–H), d 2.242 (s,1H, attached thiazolidine ring), 3.836 ppm (s, 1H –1H of thi-
azolidine ring), 2.445 ppm (s, 2H –S–CH2), d 8.167 ppm
(O‚C–NH, 1H of hydrazide) d 3.855 ppm (Ar–NH, 1H of
hydrazide). 13C NMR (CDCl3, 200 MHz): d 115.7–133.4 ppm
(Ar–C, 12C benzene ring), d 160.4 ppm (Ar–C‚O, 1C of quin-
oline), d 146.5, 128.7 ppm (Ar–C–N, 2C of quinoline), d
30.3 ppm (O‚C–C, 1C of ester), d 160.4 ppm (Ar–C–S, 1C,
of quinoline), d 170.2 ppm (NH–C‚O, 1C of hydrazide), d
162.8 ppm (Ar–C–F, 1C) d 133.3 ppm (Ar–C–NO2, 1C, of
Schiff base), 120.7 ppm, d 132.6 (Ar–C‚C 2C), d 146.5 ppm
(NH–N‚C, 1C, of hydrazide), d 169.4 ppm (–C‚O, 1C of
thiazolidine ring), d 35.6 ppm (–C–SH, 1C of thiazolidine ring)
MS: m/z (relative intensity %) (63%) M+344 amu Anal Calcd
(%) for C25H18FN4O2S: C, 55.50; H, 3.36; N, 10.36%);
Found: C, 55.49; H, 3.35; N, 10.35%.
Figure 2 Possible mass fragmentation of 2-(3-(4-ﬂuorophenyl)-4-oxo-3,4-dihyroquinazolin-2-ylthio)-N-(2-(4-chlorophenyl)-4-oxothiaz-
olidin-3-yl)acetamide.
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chlorophenyl)-4-oxo-thiazolidine-3-yl)2-(3-(4-Fluorophenyl)-
4-oxo-3,4-dihyroquinazolin-2-yl-thioacetamide (AJ5e)
Yield: 60%. M.p.- 242 C. IR (KBr): 1157 cm1 (–C–O stretch-
ing), 1341 cm1 (Ar–C–H bending), 876 cm1 (p-substituted
benzene ring), 688 cm1 (C–S stretching), 1730 cm1(C‚O
stretching of benzene ring), 1437 cm1 (Ar–C‚C Aromatic
stretching band), 1018 cm1 (Ar–F stretching), 1653 cm1
(C‚N stretching in quinoline), 2927 cm1 (–CH stretching –
CH3 & –CH2), 3207 cm
1 (–NH stretching of primary amide),
3145 cm1 (–NH stretching of secondary amide), 1508,
1341 cm1 (Ar–C–NO2 stretching band of Schiff base).
1H
NMR (CDCl3, 200 MHz): d 6.615–7.177 ppm (s, 12H, –Ar–
H), d 2.245 (s, 1H, attached thiazolidine ring), 3.834 ppm (s,
1H –1H of thiazolidine ring), 2.447 ppm (s, 2H –S–CH2), d
8.169 ppm (O‚C–NH, 1H of hydrazide) d 3.856 ppm (Ar–
NH, 1H of hydrazide). 13C NMR (CDCl3, 200 MHz): d
115.7–133.2 ppm (Ar–C, 12C benzene ring), d 160.4 ppm (Ar–
C‚O, 1C of quinoline), d 146.4, 128.3 ppm (Ar–C–N, 2C of
quinoline), d 35.3 ppm (O‚C–C, 1C of ester), d 160.4 ppm
(Ar–C–S, 1C, of quinoline), d 169.4 ppm (NH–C‚O, 1C of
hydrazide), d 162.9 ppm (Ar–C–F, 1C) d 133.2 ppm (Ar–C–
NO2, 1C, of Schiff base), 120.5 ppm, d 132.5 (Ar–C‚C 2C), d
146.4 ppm (NH–N‚C, 1C, of hydrazide), d 169.4 ppm
(–C‚O, 1C of thiazolidine ring), d 35.3 ppm (–C–SH, 1C of thi-
azolidine ring) MS: m/z (relative intensity %) (72%) M+
443 amu Anal Calcd (%) for C25H18FN4O2S: C, 55.50; H,
3.36; N, 10.37%); Found: C, 55.50; H, 3.35; N, 10.36%.5.6. Elemental and characterization data of 2-(3-(4-
ﬂuorophenyl)-4-oxo-3,4-dihyroquinazolin-2-ylthio)-N-(2-(4-
nitrophenyl)-4-oxothiazolidine-3-yl)acetamide (AJ5f)
Yield: 62%. M.p.- 246 C. IR (KBr): 1157 cm1 (–C–O stretch-
ing), 1342 cm1 (Ar–C–H bending), 876 cm1 (p-substituted
benzene ring), 689 cm1 (C–S stretching), 1728 cm1(C‚O
stretching of benzene ring), 1439 cm1 (Ar–C‚C Aromatic
stretching band), 1018 cm1 (Ar–F stretching), 1653 cm1
(C‚N stretching in quinoline), 2927 cm1 (–CH stretching –
CH3 & –CH2), 3203 cm
1 (–NH stretching of primary amide),
3144 cm1 (–NH stretching of secondary amide), 1508,
1342 cm1 (Ar–C–NO2 stretching band of Schiff base).
1H
NMR (CDCl3, 200 MHz): d 6.617–7.172 ppm (s, 12H, –Ar–
H), d 2.247 (s, 1H, attached thiazolidine ring), 3.836 ppm (s,
1H –1H of thiazolidine ring), 2.446 ppm (s, 2H –S–CH2), d
8.167 ppm (O‚C–NH, 1H of hydrazide) d 3.857 ppm (Ar–
NH, 1H of hydrazide). 13C NMR (CDCl3, 200 MHz): d
115.6–133.3 ppm (Ar–C, 12C benzene ring), d 160.4 ppm (Ar–
C‚O, 1C of quinoline), d 146.5, 128.4 ppm (Ar–C–N, 2C of
quinoline), d 35.3 ppm (O‚C–C, 1C of ester), d 160.4 ppm
(Ar–C–S, 1C, of quinoline), d 169.6 ppm (NH–C‚O, 1C of
hydrazide), d 162.9 ppm (Ar–C–F, 1C) d 133.2 ppm (Ar–C–
NO2, 1C, of Schiff base), 120.5 ppm, d 132.5 (Ar–C‚C 2C), d
146.3 ppm (NH–N‚C, 1C, of hydrazide), d 169.5 ppm
(–C‚O, 1C of thiazolidine ring), d 35.3 ppm (–C–SH, 1C of thi-
azolidine ring) MS: m/z (relative intensity %) (69%) M+
412 amu Anal Calcd (%) for C25H18FN5O5S2: C, 54.44; H,
3.29; N, 12.70%); Found: C, 55.43; H, 3.28; N, 12.70%.
Table 2 Antimicrobial and antitubercular activity results of screening compounds (AJ5a–j).
Compound
code
Ar Minimal inhibition concentrations (bacteria)
in lg/mL ± SD
Minimal inhibition concentrations (fungi)
in lg/mL ± SD
Minimal inhibition concentrations
in lg/mL ± SD
E. coli
MTCC 443
P. aeruginosa
MTCC 1688
S. aureus
MTCC 96
S. pyogenus
MTCC 442
C. albicans
MTCC 227
A. niger
MTCC 282
A. clavatus
MTCC 1323
(Antitubercular
activity%)
M. tuberculosis
H37Rv strain
AJ5a 4-Cl–C6H4 200 ± 3.161
** 250 ± 3.874** 100 ± 2.582*** 200 ± 2.854** 1000 ± 4.941* 1000 ± 5.507* 100 ± 1.68*** 25 ± 1.63
AJ5b 2-NO2–C6H4 125 ± 3.082
*** 250 ± 2.639** 250 ± 3.617** 200 ± 3.855** 1000 ± 5.468 1000 ± 4.385* 250 ± 3.603** 12 ± 3.24
AJ5c 3-NO2–C6H4 200 ± 3.647
** 200 ± 3.489** 200 ± 3.381** 250 ± 2.087** 1000 ± 4.691* 1000 ± 3.138* 200 ± 2.948** 37 ± 1.96
AJ5d 2-Cl–C6H4 250 ± 2.676
** 250 ± 1.091** 100 ± 3.265*** 200 ± 1.646** 1000 ± 5.217 1000 ± 5.310 100 ± 2.198*** 84 ± 3.601**
AJ5e 3-Cl–C6H4 125 ± 3.114
*** 125 ± 1.736*** 62.5 ± 2.080*** 200 ± 2.314** 1000 ± 3.303* 500 ± 3.354** 62.5 ± 1.966*** 51 ± 2.137
AJ5f 4-NO2–C6H4 100 ± 2.151
*** 200 ± 2.795** 200 ± 2.737** 200 ± 2.781** 1000 ± 4.600 500 ± 1.758** 200 ± 4.329** 29 ± 2.280
AJ5g 4-OCH3–C6H4 100 ± 1.105
*** 250 ± 4.338** 125 ± 3.335*** 125 ± 3.330*** 500 ± 3.108** 250 ± 1.776** 125 ± 1.505*** 32 ± 2.714
AJ5h 2-OH–C6H4 250 ± 2.340
** 200 ± 3.918** 200 ± 3.837** 200 ± 1.855** 500 ± 2.113** 1000 ± 1.519* 200 ± 3.918** 82** ± 1.835*
AJ5i 3-OH–C6H4 200 ± 2.938
** 200 ± 3.091** 125 ± 3.402*** 250 ± 3.234** 500 ± 1.157** 250 ± 2.519** 125 ± 2.686*** 80 ± 1.897*
AJ5j 4-F–C6H4 200 ± 2.396
** 250 ± 2.806** 250 ± 2.752** 250 ± 3.406** 250 ± 1.802* 250 ± 3.294** 250 ± 3.219** 80 ± 1.033*
Ampicillin 100 ± 1.823 – 250 ± 1.533 100 ± 1.373 – – – –
Chloramphenicol 50 ± 2.123 50 ± 2.243 50 ± 1.833 50 ± 1.753 – – – –
Gentamycin 0.05 ± 0.02 1 ± 0.243 0.25 0.5 ± 0.123 – – – –
Ciproﬂoxin 25 ± 1.638 25 ± 1.343 50 ± 1.353 10 ± 1.253 – – – –
Norﬂoxacin 10 ± 2.158 10 ± 2.143 10 ± 2.253 10 ± 1.653 – – – –
Nystatin – – – – – 100 ± 1.533 100 ± 1.563 –
Greseofulvin – – – – – – 100 ± 2.533 –
Isoniazide – – – – – – – 99 ± 2.343
± SD= Standard deviation. All values are presented as mean of six experiments (replicate measurement, n= 6).
These results were calculated on a one-way Bornferroni test.
* P< 0.05 = Signiﬁcant value.
** P< 0.01 =Moderately signiﬁcant value.
*** P< 0.001 = Extremely signiﬁcant value.
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ﬂuorophenyl)-4-oxo-3,4-dihyroquinazolin-2-ylthio)-N-(2-(4-
methoxyphenyl)-4-oxothiazolidine-3-yl)acetamide (AJ5g)
Yield: 53%. M.p.- 278 C. IR (KBr): 1710 cm1 (–C–O
stretching), 1342 cm1 (Ar–C–H bending), 876 cm1 (p-substi-
tuted benzene ring), 689 cm1 (C–S stretching),
1730 cm1(C‚O stretching of benzene ring), 1428 cm1 (Ar–
C‚C Aromatic stretching band), 1019 cm1 (Ar–F stretch-
ing), 1619 cm1 (C‚N stretching in quinoline), 2927 cm1
(–CH stretching –CH3 & –CH2), 3207 cm
1 (–NH stretching
of primary amide), 3143 cm1 (–NH stretching of secondary
amide). 1H NMR (CDCl3, 200 MHz): d 6.615–7.171 ppm (s,
12H, –Ar–H), d 2.247 (s, 1H, attached thiazolidine ring),
3.838 ppm (s, 1H –1H of thiazolidine ring), 2.447 ppm (s, 2H
–S–CH2), d 8.165 ppm (O‚C–NH, 1H of hydrazide) d
3.855 ppm (Ar–NH, 1H of hydrazide) d 2.348 (s, 3H, methoxy
group Ar–OCH3).
13C NMR (CDCl3, 200 MHz): d 114.2–
130.7 ppm (Ar–C, 12C benzene ring), d 160.4 ppm (Ar–
C‚O, 1C of quinoline), d 146.5, 128.4 ppm (Ar–C–N, 2C of
quinoline), d 35.3 ppm (O‚C–C, 1C of ester), d 160.4 ppm
(Ar–C–S, 1C, of quinoline), d 170.3 ppm (NH–C‚O, 1C of
hydrazide), d 162.9 ppm (Ar–C–F, 1C) d 132.7 ppm (Ar–C–
NO2, 1C, of Schiff base), 120.5 ppm, d 132.2 (Ar–C‚C 2C),
d 146.3 ppm (NH–N‚C, 1C, of hydrazide), d 169.5 ppm
(–C‚O, 1C of thiazolidine ring), d 35.3 ppm (–C–SH, 1C of
thiazolidine ring) d 55.8 ppm (–OCH3, 1C of attached substitu-
tion) MS: m/z (relative intensity %) (67%) M+ 359 amu Anal
Calcd (%) for C26H21FN4O4S2: C, 58.20; H, 3.94; N, 10.40%);
Found: C, 58.18; H, 3.93; N, 10.40%.
5.8. Elemental and characterization data of 2-(3-(4-
ﬂuorophenyl)-4-oxo-3,4-dihyroquinazolin-2-ylthio)–N-(2-(2-
hydroxyphenyl)-4-oxothiazolidine-3-yl)acetamide (AJ5h)
Yield: 58%. M.p.- 234 C. IR (KBr): 1158 cm1 (–C–O
stretching), 1341 cm1 (Ar–C–H bending), 876 cm1 (p-substi-
tuted benzene ring), 655 cm1 (C–S stretching),
1730 cm1(C‚O stretching of benzene ring), 1439 cm1 (Ar–
C‚C Aromatic stretching band), 1019 cm1 (Ar–F stretch-
ing), 1619 cm1 (C‚N stretching in quinoline), 2928 cm1
(–CH stretching –CH3 & –CH2), 3205 cm
1 (–NH stretching
of primary amide), 3145 cm1 (–NH stretching of secondary
amide), 3405 cm1 (Ar–OH stretching band). 1H NMR
(CDCl3, 200 MHz): d 6.619–7.175 ppm (s, 12H, –Ar–H), d
2.239 (s, 1H, attached thiazolidine ring), 3.836 ppm (s, 1H –
1H of thiazolidine ring), 2.448 ppm (s, 2H –S–CH2), d
8.167 ppm (O‚C–NH, 1H of hydrazide) d 3.868 ppm (Ar–
NH, 1H of hydrazide) d 3.342 (s, 1H, methoxy group Ar–
OH). 13C NMR (CDCl3, 200 MHz): d 114.2–130.7 ppm (Ar–
C, 12C benzene ring), d 161.3 ppm (Ar–C‚O, 1C of quino-
line), d 145.3, 127.3 ppm (Ar–C–N, 2C of quinoline), d
35.2 ppm (O‚C–C, 1C of ester), d 161.5 ppm (Ar–C–S, 1C,
of quinoline), d 170.6 ppm (NH–C‚O, 1C of hydrazide), d
163.7 ppm (Ar–C–F, 1C) d 132.9 ppm (Ar–C–NO2, 1C, of
Schiff base), 121.3 ppm, d 132.4 (Ar–C‚C 2C), d 146.3 ppm
(NH–N‚C, 1C, of hydrazide), d 169.6 ppm (–C‚O, 1C of
thiazolidine ring), d 35.3 ppm (–C–SH, 1C of thiazolidine ring)
MS: m/z (relative intensity %) (62%) M+ 364 amu Anal Calcd
(%) for C25H19FN4O4S2: C, 57.46; H, 3.66; N, 10.72%);
Found: C, 57.45; H, 3.66; N, 10.71%.5.9. Elemental and characterization data of 2-(3-(4-
ﬂuorophenyl)-4-oxo-3,4-dihyroquinazolin-2-ylthio)-N-(2-(3-
hydroxyphenyl)-4-oxothiazolidine-3-yl)acetamide (AJ5i)
Yield: 63%. M.p.- 267 C. IR (KBr): 1158 cm1 (–C–O
stretching), 1340 cm1 (Ar–C–H bending), 876 cm1 (p-
substituted benzene ring), 689 cm1 (C–S stretching),
1732 cm1(C‚O stretching of benzene ring), 1440 cm1
(Ar–C‚C Aromatic stretching band), 1019 cm1 (Ar–F
stretching), 1619 cm1 (C‚N stretching in quinoline),
2928 cm1 (–CH stretching –CH3 & –CH2), 3205 cm
1
(–NH stretching of primary amide), 3145 cm1 (–NH stretching
of secondary amide), 3405 cm1 (Ar–OH stretching band). 1H
NMR (CDCl3, 200 MHz): d 6.613–7.174 ppm (s, 12H, –Ar–
H), d 2.239 (s, 1H, attached thiazolidine ring), 3.836 ppm (s,
1H –1H of thiazolidine ring), 2.445 ppm (s, 2H –S–CH2), d
8.122 ppm (O‚C–NH, 1H of hydrazide) d 3.848 ppm (Ar–
NH, 1H of hydrazide). 13C NMR (CDCl3, 200 MHz): d
115.5–130.7 ppm (Ar–C, 12C benzene ring), d 162.4 ppm (Ar–
C‚O, 1C of quinoline), d 145.8, 127.8 ppm (Ar–C–N, 2C of
quinoline), d 35.5 ppm (O‚C–C, 1C of ester), d 162.4 ppm
(Ar–C–S, 1C, of quinoline), d 170.2 ppm (NH–C‚O, 1C of
hydrazide), d 163.4 ppm (Ar–C–F, 1C), 121.6 ppm, d 132.5
(Ar–C‚C 2C), d 146.3 ppm (NH–N‚C, 1C, of hydrazide), d
169.8 ppm (–C‚O, 1C of thiazolidine ring), d 35.4 ppm (–C–
SH, 1C of thiazolidine ring) MS: m/z (relative intensity %)
(67%) M+ 378 amu Anal Calcd (%) for C25H19F2N4O4S2: C,
57.24; H, 3.46; N, 10.68%); Found: C, 57.23; H, 3.45; N,
10.68%.
5.10. Elemental and characterization data of 2-(3-(4-
ﬂuorophenyl)-4-oxo-3,4-dihyroquinazolin-2-ylthio)-N-(2-(4-
ﬂuorophenyl)-4-oxothiazolidine-3-yl)acetamide (AJ5j)
Yield: 62%. M.p.- 246 C. IR (KBr): 1157 cm1 (–C–O
stretching), 1345 cm1 (Ar–C–H bending), 875 cm1 (p-
substituted benzene ring), 687 cm1 (C–S stretching),
1728 cm1(C‚O stretching of benzene ring), 1438 cm1
(Ar–C‚C Aromatic stretching band), 1019 cm1 (Ar–F
stretching), 1654 cm1 (C‚N stretching in quinoline),
2927 cm1 (–CH stretching –CH3 & –CH2), 3204 cm
1
(–NH stretching of primary amide), 3144 cm1 (–NH
stretching of secondary amide). 1H NMR (CDCl3,
200 MHz): d 6.617–7.172 ppm (s, 12H, –Ar–H), d 2.247 (s,
1H, attached thiazolidine ring), 3.836 ppm (s, 1H –1H of thi-
azolidine ring), 2.446 ppm (s, 2H –S–CH2), d 8.167 ppm
(O‚C–NH, 1H of hydrazide) d 3.857 ppm (Ar–NH, 1H of
hydrazide). 13C NMR (CDCl3, 200 MHz): d 115.6–
133.3 ppm (Ar–C, 12C benzene ring), d 160.4 ppm (Ar–
C‚O, 1C of quinoline), d 146.5, 128.4 ppm (Ar–C–N, 2C
of quinoline), d 35.3 ppm (O‚C–C, 1C of ester), d
160.4 ppm (Ar–C–S, 1C, of quinoline), d 169.6 ppm (NH–
C‚O, 1C of hydrazide), d 162.9 ppm (Ar–C–F, 1C) d
133.2 ppm (Ar–C–NO2, 1C, of Schiff base), 120.5 ppm, d
132.5 (Ar–C‚C 2C), d 146.3 ppm (NH–N‚C, 1C, of
hydrazide), d 169.5 ppm (–C‚O, 1C of thiazolidine ring),
d 35.3 ppm (–C–SH, 1C of thiazolidine ring) MS: m/z (rela-
tive intensity %) (69%) M+ 352 amu Anal Calcd (%) for
C25H18F2N4O3S2: C, 57.24; H, 3.46; N, 10.68%); Found:
C, 57.23; H, 3.45; N, 10.67%.
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The newly synthesized compounds AJ5a–j were screened for
their antimicrobial activity against Gram-positive bacteria
Staphylococcus aureus (MTCC-96), Streptococcus pyogenes
(MTCC-442) and Gram negative (Escherichia coli (MTCC-
443), Pseudomonas aeruginosa (MTCC-1688). And fungal
pathogens Candida albicans (MTCC 227), Aspergillus niger
(MTCC 282) and Aspergillus clavatus (MTCC 1323) All
MTCC cultures were collected from the Institute of Micro-
bial Technology, Chandigarh. The activity of compounds
was determined as per Microcare Laboratory Surat
Standard protocol using Mueller–Hinton Broth (Becton–
Dickinson, USA) (Al-Bayani and Al-Mola, 2008; Finegold
and Garrod, 1995). The Compounds were further dissolved
in dimethyl sulfoxide (DMSO) for the disc diffusion test,
and minimal inhibitory concentrations (MIC) were deter-
mined by making a series of dilutions in an appropriate
substrate ranging from (5–250 lg/mL). The ﬁnal concentra-
tion of DMSO did not exceed 2%. The sensitivity of micro-
organisms to the investigated species was tested by
measuring the zone of inhibition of a given concentration
of the extract by the disc-diffusion method and by determin-
ing the minimal inhibitory concentration (MIC). Bacterial
inoculants were obtained from bacterial cultures incubated
for 24 h at 37 C on Mueller–Hinton agar substrate and di-
luted to approximately 108 CFU/mL, according to the 0.5
McFarland standard. Suspensions of fungal spores were pre-
pared from fresh mature (3–7 days old) cultures that grew at
30 C on a PDA substrate. Spores were rinsed with sterile
distilled water, in order to determine turbidity spectrophoto-
metrically at 530 nm, and then further diluted to approxi-
mately 106 CFU/mL according to the procedure
recommended by the NCCLS (CLSI; formerly NCCLS).
The standard disc-diffusion method was used to study anti-
microbial activity. The appropriate inoculums were seeded
in Mu¨eller–Hinton agar (for bacteria) or SD agar (for fungi)
in Petri dishes. Paper discs (7 mm in diameter) were laid on
the inoculated substrate after being soaked with 15 lL of
different concentrations of 5–250 lg/mL. Antimicrobial
activity was determined by measuring the diameter of the
zone of inhibition around the disc. As a positive control
of growth inhibition, ampicillin, gentamycin, ciproﬂoxin,
norﬂoxacin and chloramphenicol were used in the case of
bacteria, nystatin, greseofulvin in the case of fungi. A
DMSO solution was used as a negative control for the
inﬂuence of solvents and all experiments were performed
in duplicate. The minimal inhibitory concentration (MIC)
was determined by the broth tube dilution method. A series
of dilutions with concentrations ranging from 5–250 lg/mL
was used in the experiment with each extract for every
microorganism tested. The starting solutions of compound
with a concentration of 5 lg/mL were obtained by measur-
ing a certain quantity of the compound and dissolving it in
DMSO. Twofold dilutions of compound were prepared in
Mu¨eller–Hinton bullion for bacterial cultures and SD bul-
lion for fungal cultures in test tubes. The boundary dilution
without any visible growth was deﬁned as the minimal
inhibitory concentration (MIC) for the tested microorganism
at the given compound’s concentration. All experiments
were performed in duplicate.5.12. Antimicrobial assay
Compounds AJ5a–j were evaluated against gram-positive,
gram-negative bacteria and fungi strains. Compounds AJ5b,
AJ5e, AJ5f, AJ5g (MIC = 62.5–125 lg/mL for each) were
found to have a good activity while compounds AJ5a, AJ5c,
AJ5d, AJ5h, AJ5i, AJ5j were also found to have a moderate
activity against E. coli bacteria (MIC = 200–250 lg/mL for
each), similarly compounds AJ5a, AJ5b, AJ5c, AJ5d, AJ5f,
AJ5g, AJ5h, AJ5j showed a moderate activity, while compound
AJ5e, showed a good activity against P. aeruginosa with
MIC = 62.5–100 lg/mL for each compound. Compounds
AJ5a, AJ5d, AJ5g, AJ5i showed a good activity and com-
pounds AJ5b, AJ5c, AJ5f, AJ5h, AJ5j were moderately active
and compound AJ5e was also with an excellent activity against
S. aureus with MIC = ranging from 62.5 to 100 lg/mL. Com-
pound AJ5g showed a good activity against S. pyogenus with
MIC = 100 lg/mL. Results also suggest that compounds
AJ5a, AJ5e, AJ5g are more effective against all bacterial strain
studies in the present work. Results of antifungal activity sug-
gest that the synthesized compounds were effective against
three fungal pathogens. Compound AJ5j showed a good activ-
ity and compounds AJ5g, AJ5h, AJ5i were moderately active
against C. albicans and compounds AJ5g, AJ5i, AJ5j showed
a moderate activity against A. niger with MIC = 62.5–
100 lg/mL for each compound, compounds AJ5a, AJ5d,
AJ5g, AJ5i showed a good activity compounds AJ5b, AJ5c,
AJ5f, AJ5h, AJ5j were moderately active and compound
AJ5e showed an excellent activity against A. clavatus with
MIC = 62.5–100 lg/mL. The data revealed that electron-
releasing groups like Flouro, hydroxyl, nitro, chloro and
methoxy, present on phenyl ring are found to increase the anti-
bacterial property. These results clearly demonstrated that
when compound 4 converted into corresponding ﬁnal com-
pounds AJ5a–j, they exhibited an antimicrobial activity. Most
of the synthesized compounds exhibited a signiﬁcant antibacte-
rial activity and a moderate antifungal activity. On the basis of
MIC values, it is our observation that the presence of 4-F, 4-
NO2, 2-OH, 4-Cl, 4-CH3 and 4-OCH3 groups at the position
of thiazolidine ring led to a signiﬁcant variation in the antimi-
crobial activity. A series of compounds when substituted by
electron-releasing groups like ﬂouro hydroxyl, chloro, nitro
and methoxy present on the aromatic ring enhanced the anti-
microbial activity.
5.13. Antitubercular activity
5.13.1. Morphology
These are nonmotile, nonsporing and noncapsulated bacilli,
arranged singly or in groups.
They are acid-fast due to the presence of mycolic acid in
cell-wall and weakly Gram positive. With Ziehl–Neelsen stain,
M. tuberculosis look slender, straight or slightly curved rod
with beaded or barred appearance and Mycobacterium bovis
appear straighter, stouter and shorter with uniform staining.
5.13.2. Culture
Tubercle bacilli are aerobes, grow slowly (generation time 14–
15 h), optimum temperature 37 C, pH 6.4–7.0. They grow
only in specially enriched media containing egg, asparagines,
S534 D.R. Godhani et al.potatoes, serum and meat extracts. Colonies appear in 2–
6 weeks.
M. tuberculosis grows more luxuriantly in culture (eugenic)
thanM.bovis, which grows sparsely (dysgenic). The direct drug
susceptibility test is performed by using a subculture from a
primary culture as the inoculums. Determination of MIC
was carried out by L.J. Slope method.
5.13.3. Primary screen
In primary screening 500 lg/mL, 250 lg/mL, and 125 lg/mL
concentrations of the synthesized drugs were taken. The active
synthesized drugs found in this primary screening were further
tested in a second set of dilution against all microorganisms.
5.13.4. Secondary screen
The drugs found to be active in primary screening were simi-
larly diluted to obtain 100 lg/mL, 50 lg/mL, 25 lg/mL,
12.5 lg/mL, 6.250 lg/mL, 3.125 lg/mL and 1.5625 lg/mL
concentrations.
5.14. Antitubercular assay
The results of the antitubercular activity are summarized in
Table 1. All compounds were screened for their antitubercular
activity against M. tuberculosis (H37Rv strain). The investiga-
tion of antimicrobial data revealed that compounds AJ5b,
AJ5e, AJ5f, AJ5g, AJ5i and AJ5e displayed a good activity,
and the other compounds showed less activity against all the
strains compared with standard drugs. The compounds exhib-
ited a structure–activity relationship (SAR) because the activ-
ity of compounds varies with substitution. The 3-chloro, 2-
nitro, 4-methoxy group-containing compounds AJ5e, AJ5f
and AJ5g showed a higher activity than the hydroxy and ﬂouro
groups (AJ5i and AJ5j) or in addition, the chloro, nitro, meth-
oxy derivatives also had a higher activity than the other expe-
rienced compounds. Based on the SAR, it could be concluded
that the activity of compounds depended on the electron with-
drawing nature of the substituent groups.
6. Conclusion
In present paper we have disclosed the 4-oxo-thiozolidine con-
densation synthesis and their biological evaluation. This synthe-
sis of 4-oxo-thiozolidine was therefore, superior in simplicity
and yield compared to alternative multistep strategies that have
been reported earlier. A series of 2-(3-(4-ﬂuorophenyl)-4-oxo-
3,4-dihyroquinazolin-2-ylthio)-N-(2-(4-chlorophenyl)-4-oxo-
thiazolidine-3-yl)acetamide (AJ5a–j)were synthesized andwere
characterized by spectroscopic techniques. The antimicrobial
activity and proﬁle of the title compounds were evaluated
against Gram positive, Gram negative bacteria and fungal
pathogens. Antitubercular activity of the AJ5a–j compounds
was evaluated againstM. tuberculosis (H37Rv strain). They pos-
sessed activity againstM. tuberculosis (H37Rv strain). It can be
concluded that the compounds bearing Ar = 4-ﬂouro, 4-
chloro, 2-hydroxy, 3-nitro, 3-hydroxy, 4-methoxy and 4-nitro
substituents are more potent than the remaining compounds.
They showed comparatively good antibacterial as well as anti-
fungal and antitubercular activities. Looking to the SAR, a
remarkable relationship was observed in compounds AJ5a–j.for decreasing or increasing antimicrobial or antitubercular
activities.
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